ESMED Congress 2021
Hilton Vienna Danube Waterfront Hotel
Feedback from ESMED Congress 2021
The ESMED General Assembly (2022) allowed me to present my work on new optimization methods in drug discovery at the preclinical level to a much wider audience of patient-related doctors and clinicians; not many conferences are able to bridge this gap.
Celerino Abad-Zapatero, Ph.D.
University of Illinois at Chicago
I wish to thank you for the opportunity you gave to me to present in your congress in Vienna in 2021 our new approach of the melanoma problem. Also the active participation of the audience was not just a common one. In between I hope that until your next congress this year we will have more new results to present.
To have an idea is the first step, but to arrive even to results is the ultimate step.
Konstantin Zioutas
University of Patras
It has been a very complete congress covering all areas of knowledge. My experience was very satisfactory, I received the necessary help from the organization and the virtual presentation was excellent.
Carlos Morales
Hospital Universitario Central de Asturias
Related to the past ESMED 2021 congress in Viena my experience was good. Both, the Organization and Congress were of high quality. However, in my case, the problem was that only few attendants were during my talk, maybe as a consequence of having two rooms functioning at the same time that could be merged.
Diego Caicedo Valdés, MD, PhD.
Universitario de Santiago de Compostela
November 11-13, 2021
Vienna, Austria + Online
The ESMED Congress is a congress like no other: cutting-edge research, world-renowned speakers, and the opportunity to connect with colleagues from across the globe. Our goal is to deliver an exceptional scientific program which inspires and challenges medical professionals to reach their next great discovery.
We invite you to submit your work and reserve your place by registering early for an unforgettable experience.
Call for Science
Nowhere else will your science have such a significant impact on a global stage. By being a part of the ESMED Congress Program your work will be exposed to the international medical community in a modern learning environment.
Global recognition for your work
- Dozens of countries represented
- Network with top experts in the field
- International exposure for your research
High visibility & impact
- Present before key leaders in your field
- Inclusion in the conference program & proceedings
- All presentations published in the ESMED video library
Presentation Types
Keynote presentation
25-40 minutes
Session presentation
20-30 minutes
Poster presentation
5-15 Minutes
Online presentation
20-35 Minutes
Feedback from ESMED Congress 2021
The ESMED General Assembly (2022) allowed me to present my work on new optimization methods in drug discovery at the preclinical level to a much wider audience of patient-related doctors and clinicians; not many conferences are able to bridge this gap.
Celerino Abad-Zapatero, Ph.D.
University of Illinois at Chicago
I wish to thank you for the opportunity you gave to me to present in your congress in Vienna in 2021 our new approach of the melanoma problem. Also the active participation of the audience was not just a common one. In between I hope that until your next congress this year we will have more new results to present.
To have an idea is the first step, but to arrive even to results is the ultimate step.
Konstantin Zioutas
University of Patras
Related to the past ESMED 2021 congress in Viena my experience was good. Both, the Organization and Congress were of high quality. However, in my case, the problem was that only few attendants were during my talk, maybe as a consequence of having two rooms functioning at the same time that could be merged.
Diego Caicedo Valdés, MD, PhD.
Universitario de Santiago de Compostela
Important Deadlines
12 March 2021
Early abstract submission deadline
2 April 2021
Early registration savings
1 August 2021
Final abstract submission deadline
ESMED Congress 2021 Program
We are working relentlessly to assemble a scientific program which will showcase the latest knowledge in an interactive and modern platform.
This year’s spotlight: Global Public Health
The Coronavirus pandemic has moved public health into the spotlight on an unprecedented scale. Preventing disease requires organized efforts and evidence-based policy options. Analyzing the threats to the health of a population is a difficult challenge which needs multidisciplinary input and careful consideration of the facts. At ESMED Congress 2021 leading public health experts will talk about how we can reduce the global burden of disease and prevent the next pandemic.
Chaired by Virginia Lynch, Academy of Forensic Nursing
Trends in Oncology
Cancer is the second leading cause of death globally, and is responsible for approximately 10 million deaths annually. ESMED hopes to reduce the burden of cancer by helping to shape healthcare policy in three key areas: Prevention strategies, Early detection, and Treatment.
Chaired by Borje S. Andersson, M.D., Ph.D., MD Anderson Cancer Center
A New Era for Neuroscience
New discoveries within the Neuroscience field are constantly shaping our understanding of the brain and the nervous system. ESMED Congress 2021 will have an emphasis on the following Neuroscience topics: Alzheimers, Epilepsy, Glioblastoma, and Neuronanotechnology.
Chaired by Valery Shestopalov, Ph.D., University of Miami
Exploring Genetics & Genomics
During the last decade there have been enormous advancements in the field of Genetics which have widespread implications across virtually all diseases. Genome editing has the ability to revolutionize medicine, but also poses many challenges. ESMED Congress 2021 will explore the latest innovations in genetics and genomics, with the goal of encouraging a multidisciplinary approach to genetics research.
Chaired by Douglas Andres, Ph.D., University of Kentucky
Advancements in Cardiology
Cardiovascular disease causes 3.9 million deaths in Europe each year. Risk factors such as obesity and diabetes have increased in recent years, resulting in the need for new approaches to reducing the burden of cardiovascular disease. ESMED Congress 2021 aims to advance cardiovascular knowledge in three key areas: Prevention strategies, Early detection, and Treatment.
Chaired by Valery Shestopalov, University of Miami
Advancing Knowledge in Diabetes
The prevalence of Diabetes in Europe has grown to an alarming 10% of adults. Breakthroughs in Diabetes care are urgently needed. ESMED Congress 2021 will examine the latest technologies and ideas for Diabetes care.
Chaired by Philippe Valet, Ph.D., INSERM
Nutrition & Food Science
The fields of Nutrition and Food Science experience rapid change as new technologies become available. ESMED Congress 2021 aims to advance nutrition knowledge be exploring the latest innovation in the field.Chaired by Matthew Moore, University of Massachusetts
Pharmacology Trends
Spotlight on Surgery
Nutrition & Food Science
Focus on Neonatology
Medical Nanotechnology
The Future of Psychology
Breakthroughs in Pediatrics
Nursing/Healthcare Management
Trends in Endocrinology
Next Generation Immunology
Focus on Pulmonology
Advancements in Physiology
Featured Keynote Speakers
Terrence Murphy
Yale School of Medicine
Integration of Fall Prevention into State Policy in Connecticut
Dr. Murphy is a member of the biostatistics staff of the Program on Aging. With twelve years experience in the design and manufacture of clinical instrumentation and advanced training in engineering statistics, he is interested in the application of engineering tools to research on aging. Current areas of investigation include multivariate statistics for characterization of multiple co–morbidity, robust design techniques for assessing the tradeoffs of multiple medication use, and the use of hierarchical models, propensity scores, and Bayesian techniques to enhance the analysis of non-randomized interventional designs such as the fall–related utilization of healthcare services by older persons in the state of Connecticut.
Helen Noble
Queen’s University Belfast
Mindfulness Based Interventions for people for kidney disease
Dr Helen Noble’s research is focused on two areas; (i) improving the quality of life of people with end-stage kidney disease (and their carers) from diagnosis through to end of life.
Joan-Lluis Vives-Corrons
University of Barcelona
Diagnostic approach of hereditary red blood cell membranopathies: From Osmotic Gradient Ektacytometry (OGE) to Next Generation Sequencing (NGS)
Joan-Lluis Vives Corrons is a Professor of Medicine (1976-present) and Head of the Red Blood Cell Pathology Unit (1997 –present) at the Hospital Clínic i Provincial (University of Barcelona), with main activity focused on the diagnosis of RBC defects and in the identification of low prevalence anaemias or “Rare Anaemias”.Research has mainly based on physiopathology, molecular mechanisms and epidemiology of red blood cell (RBC) disorders due to hereditary enzymopathies (G6PD, PK and others), haemoglobinopathies (Sickle-cell anaemia and thalassaemias) and membrane defects.
Jan Ilhan Kizilhan
Institute for Transcultural Health Science, Germany
Transcultural Aspects of Psychotraumatology in Medicine
Jan Ilhan Kizilhan is a psychologist, author and publisher, with research interests in psychotraumatology, sexual violation, trauma, terror and war, transcultural psychiatry, psychotherapy, clinical psychology and psychotherapy, migration research and socialization-war research.
Andrea Kleindienst
Dept. of Neurosurgery Univ. Erlangen-Nürnberg
Therapeutic Enhancement of Adult Neurogenesis following Brain Injury
Dr. Andrea Kleindienst was born and raised in Berlin, where she studied medicine at the Free University Berlin and earned her doctorate. She is a German board-certified neurosurgeon since 1998 and has an accreditation by the United States Educational Commission for Foreign Medical Graduates in 2003. Dr. Kleindienst completed graduation in X-Ray and computed tomography diagnostics, emergency and intensive care medicine, manual medicine/ chiropractic therapy, acupuncture, and psychosomatic medicine.
Jan Verbruggen
Maastricht University Medical Center
Pre-operative cardiac evaluation of patients with a hip fracture, still sensible?
Dr. Verbruggen studied medicine at the Catholic University of Leuven. After obtaining his medical degree, he was trained as a surgeon in the University Hospitals of the University of Leuven and the hospitals affiliated with it. In 1993 he was recognized as a General Surgeon, after which he further specialized in trauma surgery at the Klinikum in Garmisch-Partenkirchen, Germany and subsequently at the Maastricht UMC + (then Academic Hospital Maastricht). He worked for a year as Oberarzt at the Unfall Surgery department of the Klinikum in Aachen and returned to Maastricht UMC + in 1999 as a staff member for Surgery with a focus on Trauma Surgery.
Thomas F. Lüscher
Royal Brompton & Harefield Hospitals/Imperial College
Inflammation and Acute Coronary Syndromes
Professor Thomas F. Lüscher is the Director of Research, Education & Development and Consultant of Cardiology at Royal Brompton & Harefield Hospital Trust and Imperial College in London and Director of the Center for Molecular Cardiology at the University Zurich (Campus Schlieren).
From 1996 – 2017 he was Chairman of Cardiology at the University Hospital Zurich and Director of the Center for Molecular Cardiology at the University Zurich (Campus Schlieren, Wagi-Areal), Switzerland.
Jolien Gooijers
KU Leuven, Belgium
Advanced neuroimaging in relation to motor control post traumatic brain injury
The nearest airport is Vienna International Airport (VIE)
Hilton Vienna Danube Waterfront Hotel
Step 1
Cognito.load(“forms”, { id: “49”, entry: { “Event”: “ESMED Congress 2021”} });
Step 2
Payment
* Publication of one manuscript in the Medical Research Archives, the official open-access journal of the European Society of Medicine.
